About KoshKey
KoshKey is a company based in Bengaluru (India) founded in 2022 by Tanay Bhatt and Colin Jamora. The company has 1 employees as of April 09, 2024. KoshKey offers products and services including RNAi Therapy, Skin Biology Services, Histopathology Services, and Virology Services. KoshKey operates in a competitive market with competitors including MiRagen, ProQR Therapeutics, Prosensa, Cardior Pharmaceuticals and Ilya Pharma, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 09 Apr, 2024
- Founders Tanay Bhatt, Colin Jamora
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Koshkey Sciences Private Limited
- Date of Incorporation 02 May, 2022
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 09, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of KoshKey
KoshKey offers a comprehensive portfolio of products and services, including RNAi Therapy, Skin Biology Services, Histopathology Services, and Virology Services.
Therapy that silences genes to treat diabetic wounds and infections.
Provides analysis in skin biology and histopathology for medical studies.
Offers examination of tissue samples for disease research and treatment.
Conducts studies on viruses related to skin and wound infections.
Funding Insights of KoshKey
Detailed funding history for KoshKey
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by KoshKey
Investment portfolio details for KoshKey
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - KoshKey
Detailed financials for KoshKey
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Koshkey Comparisons
Peer comparison for KoshKey
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of KoshKey
KoshKey operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiRagen, ProQR Therapeutics, Prosensa, Cardior Pharmaceuticals and Ilya Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
RNA-based therapeutics are developed for genetic retinal disorders.
|
|
| Locked | Locked | Locked |
RNA-modulating therapeutics for neuromuscular disorders were developed.
|
|
| Locked | Locked | Locked |
Non-coding RNA therapeutics are developed for cardiovascular disease treatment.
|
|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
Detailed competitors of KoshKey
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Koshkey
Complete news archive for KoshKey
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KoshKey
KoshKey was founded in 2022.
KoshKey is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
As of Apr 09, 2024, the latest employee count at KoshKey is 1.
KoshKey was founded in 2022 and is headquartered in Bengaluru, India. Gene therapies targeting antimicrobial-resistant skin infections are developed by the company within the biotechnology sector. RNAi-based treatments are provided, using technology that identifies genes linked to non-healing wounds in diabetic skin and silences them. Operations center on advancing therapies for persistent skin conditions in healthcare applications.
KoshKey's top competitors include Exicure, ProQR Therapeutics and Ilya Pharma.
KoshKey offers RNAi Therapy, Skin Biology Services, Histopathology Services, and Virology Services.